Lumos sets Q3 reporting date, investor webinar as SPP enters final stretch

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has locked successful the timing for its March 4th update and capitalist briefing, portion reminding shareholders that its existent superior raising is approaching its closing date.

The institution volition merchandise its Q3 FY26 results connected April 20, followed by an capitalist webinar connected April 21, wherever absorption volition outline quarterly show and caller developments.

The webinar volition beryllium held online astatine 11:00 americium (AEST) connected April 21, with investors and analysts invited to attend. Participants tin registry astatine the pursuing link: https://us02web.zoom.us/webinar/register/WN_LGuVX42cSH6Fq0asH0O5uw

The league is expected to supply further colour connected the company’s operational progress, with a peculiar absorption connected commercialized enactment and execution crossed its diagnostics portfolio.

The update comes amid a play of accrued enactment for Lumos, including ongoing enlargement efforts successful the US for its flagship FebriDx test.

Alongside the quarterly update, Lumos is continuing its Share Purchase Plan (SPP), which opened connected April 10 and is acceptable to adjacent connected April 24 astatine 5 p.m. (AEST).

Key details of the connection include:

• One escaped attaching enactment for each 2 shares subscribed

• Pricing aligned with the caller organization placement

• Access to supporting materials via the company’s capitalist portal

The SPP follows a broader superior raising completed successful precocious March and is aimed astatine giving existing shareholders an accidental to enactment connected akin terms.

While overmuch of Lumos’ caller quality travel sits extracurricular the March quarter, it is apt to signifier capitalist absorption heading into the results.

In caller weeks, Lumos has expanded the deployment of FebriDx crossed further urgent attraction sites successful the US, secured a US$5 cardinal milestone outgo linked to regulatory progress, and continued gathering retired manufacturing capacity.

These updates constituent to increasing commercialized traction arsenic Lumos pushes further into the US market, continuing the modulation from improvement to gross generation.

The webinar besides provides a timely touchpoint for absorption to prosecute with investors arsenic the SPP nears completion, perchance supporting information up of the closing date.